- No clear beneficiaries surfaced yet.
Chronic Disease Flexible Coverage Act
Received in the Senate and Read twice and referred to the Committee on Finance.
<p><strong>Chronic Disease Flexible Coverage Act</strong></p><p>This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.</p><p>Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. </p><p>The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include</p><ul><li>angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;</li><li>anti-resorptive therapy for individuals with osteoporosis or osteopenia;</li><li>beta-blockers for individuals with congestive heart failure or coronary artery disease;</li><li>blood pressure monitors for individuals with hypertension;</li><li>inhaled corticosteroids and peak flow meters for individuals with asthma;</li><li>insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;</li><li>international normalized ratio testing for individuals with liver disease or bleeding disorders;</li><li>low-density lipoprotein testing for individuals with heart disease;</li><li>statins for individuals with heart disease or diabetes; and</li><li>selective serotonin reuptake inhibitors for individuals with depression. </li></ul><p>The bill provides statutory authority for the IRS's guidance. </p>
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The next hurdle is reproducing that support in the other chamber.
<p><strong>Chronic Disease Flexible Coverage Act</strong></p><p>This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.</p><p>Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually.
However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. </p><p>The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include</p><ul><li>angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;</li><li>anti-resorptive therapy for individuals with osteoporosis or osteopenia;</li><li>beta-blockers for individuals with congestive heart failure or coronary artery disease;</li><li>blood pressure monitors for individuals with hypertension;</li><li>inhaled corticosteroids and peak flow meters for individuals with asthma;</li><li>insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;</li><li>international normalized ratio testing for individuals with liver disease or bleeding disorders;</li><li>low-density lipoprotein testing for individuals with heart disease;</li><li>statins for individuals with heart disease or diabetes; and</li><li>selective serotonin reuptake inhibitors for individuals with depression. </li></ul><p>The bill provides statutory authority for the IRS's guidance. </p>
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
How solid the drafting looks.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- No clear downsides surfaced yet.
Why the argument around this bill splits.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
- The next hurdle is reproducing that support in the other chamber.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Chronic Disease Flexible Coverage Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.